Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City_West China Medical Journal

Authors：

 LIZhi-chao ¹ , WUJia ² ,  HUANGHe ³

1. Department of Day Surgery Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Department of General Practice, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
3. Department of Cardiology;West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

HUANGHe, Email: xhehuang@yahoo.com

Keywords：

Dyslipidemia; Cardiovascular risk; Urban resident; Epidemiology

DOI：

10.7507/1002-0179.20150531

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the prevalence status and characteristics of dyslipidemia and cardiovascular risk factors in urban communities of Chengdu city. Methods By cluster sampling, a population of 994 inhabitants were selected from 14 urban communities in Chengdu city between February and October 2010. We investigated patients between 35-70 years old who lived in the area over 2 years, by using questionnaires survey, physical examination, and laboratory tests. According to the age, the respondents were divided into three groups: young group ( ≤ 44 years old), middle-aged group (45-59 years old) and elderly group ( ≥ 60 years old). We further investigated the major cardiovascular risk factors for hyperlipidemic patients. Results The prevalence of dyslipidemia in Chengdu urban area was 28.47% (283/994), and standardized prevalence rate was 24.65% (male, 24.68%; female, 30.91%). The prevalence rate between male and female had significant diTherence (χ²=4.513, P=0.034). Female elderly group and middle-aged group had a significantly higher prevalence than the young group (P<0.05), while the male prevalence had no statistical diTherences among all age groups (P>0.05). Hypertension was most common in patients with dyslipidemia (male, 50.04%; female, 52.41%) followed by diabetes and coronary heart disease. There was no difference between male and female in the prevalence of dyslipidemia accompanied hypertension, history of stoke and coronary heart disease, abdominal obesity,or obesity (P>0.05). Higher prevalence with smoking and drinking was in male patients (P<0.05). Conclusion The prevalence of dyslipidemia is relatively high in urban communities of Chengdu city. According to the region of hyperlipemia epidemiological characteristics and risk factors, by using comprehensive intervention measures, we can reduce the prevalence of dyslipidemia.

Citation： LIZhi-chao, WUJia, HUANGHe. Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City. West China Medical Journal, 2015, 30(10): 1845-1848. doi: 10.7507/1002-0179.20150531 Copy

1.	国家心血管病中心. 中国心血管病报告2013[M]. 北京:中国大百科全书出版社, 2014:1-86.
2.	Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults[J]. Circulation, 2006, 114(21):2217-2225.
3.	D'Agostino RS, Grundy S, Sullivan LM, et al. Validation of the framingham coronary heart disease prediction scores:results of a multiple ethnic groups investigation[J]. JAMA, 2001, 286(2): 180-187.
4.	武阳丰, 赵冬, 周北凡, 等. 中国成人血脂异常诊断和危险分层方案的研究[J]. 中华心血管病杂志, 2007, 35(5):428-433.
5.	中华心血管杂志编辑委员会. 多重心血管危险因素综合防治建议[J]. 中华心血管病杂志, 2006, 12(34):1061-1071.
6.	国家"九五"科技攻关课题协作组. 我国中年人群心血管病主要危险因素流行现状及从80年代初至90年代末的变化趋势[J]. 中华心血管病杂志, 2001, 29(2):74-79.
7.	中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5):390-419.
8.	Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010[J]. N Engl J Med, 2011, 364(25):2469-2470.
9.	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20(1):81-117.
10.	陈春明, 国际生命科学学会中国办事处中国肥胖问题工作组联合数据汇总分析协作组. 中国成人体质指数分类的推荐意见简介[J]. 中华预防医学杂志, 2001, 35(5):349-350.
11.	World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings[M]. Geneva:WHO Library Cataloguing-in-Publication Data:World Health Organization, 2010:17-18.
12.	赵文华, 张坚, 由悦, 等. 中国18岁及以上人群血脂异常流行特点研究[J]. 中华预防医学杂志, 2005, 39(5):306-310.
13.	He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation, 2004, 110(4): 405-411.
14.	孙玮, 陈爱芳, 沈宇峰. 上海某中心城区931例社区居民血脂异常情况调查[J]. 健康教育与健康促进, 2014, 9(2):124-126.
15.	莫景富, 宋秀玲, 许燕君, 等. 广东省成人血脂异常患病率及其危险因素的相关性研究[J]. 华南预防医学, 2013, 39(2):11-17.
16.	邓颖, 吴先萍, 高亚礼, 等. 四川城乡居民血脂异常流行病学分析[J]. 中国慢性病预防与控制, 2006, 14(4):284-285.
17.	蔺子, 马娟珍, 闫香华, 等. 原发性高血压与血脂、血尿酸的研究进展[J]. 全科护理, 2013, 11(11):1028-1029.
18.	陈金仲, 邵豪. 脂代谢紊乱与胰岛素抵抗的相关研究进展[J]. 中国实用医药, 2008, 3(7):147-149.
19.	Xi B, Liang YJ, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009[J]. Int J Cardiol, 2012, 158(2):326-329.
20.	Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-958.
21.	戚文威, 黄建凤, 李建新, 等. 中国人群饮酒与代谢综合征发病关系的前瞻性研究[J]. 中华健康管理学杂志, 2012, 6(2):75-80.

1. 国家心血管病中心. 中国心血管病报告2013[M]. 北京:中国大百科全书出版社, 2014:1-86.
2. Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults[J]. Circulation, 2006, 114(21):2217-2225.
3. D'Agostino RS, Grundy S, Sullivan LM, et al. Validation of the framingham coronary heart disease prediction scores:results of a multiple ethnic groups investigation[J]. JAMA, 2001, 286(2): 180-187.
4. 武阳丰, 赵冬, 周北凡, 等. 中国成人血脂异常诊断和危险分层方案的研究[J]. 中华心血管病杂志, 2007, 35(5):428-433.
5. 中华心血管杂志编辑委员会. 多重心血管危险因素综合防治建议[J]. 中华心血管病杂志, 2006, 12(34):1061-1071.
6. 国家"九五"科技攻关课题协作组. 我国中年人群心血管病主要危险因素流行现状及从80年代初至90年代末的变化趋势[J]. 中华心血管病杂志, 2001, 29(2):74-79.
7. 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5):390-419.
8. Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010[J]. N Engl J Med, 2011, 364(25):2469-2470.
9. 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20(1):81-117.
10. 陈春明, 国际生命科学学会中国办事处中国肥胖问题工作组联合数据汇总分析协作组. 中国成人体质指数分类的推荐意见简介[J]. 中华预防医学杂志, 2001, 35(5):349-350.
11. World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings[M]. Geneva:WHO Library Cataloguing-in-Publication Data:World Health Organization, 2010:17-18.
12. 赵文华, 张坚, 由悦, 等. 中国18岁及以上人群血脂异常流行特点研究[J]. 中华预防医学杂志, 2005, 39(5):306-310.
13. He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation, 2004, 110(4): 405-411.
14. 孙玮, 陈爱芳, 沈宇峰. 上海某中心城区931例社区居民血脂异常情况调查[J]. 健康教育与健康促进, 2014, 9(2):124-126.
15. 莫景富, 宋秀玲, 许燕君, 等. 广东省成人血脂异常患病率及其危险因素的相关性研究[J]. 华南预防医学, 2013, 39(2):11-17.
16. 邓颖, 吴先萍, 高亚礼, 等. 四川城乡居民血脂异常流行病学分析[J]. 中国慢性病预防与控制, 2006, 14(4):284-285.
17. 蔺子, 马娟珍, 闫香华, 等. 原发性高血压与血脂、血尿酸的研究进展[J]. 全科护理, 2013, 11(11):1028-1029.
18. 陈金仲, 邵豪. 脂代谢紊乱与胰岛素抵抗的相关研究进展[J]. 中国实用医药, 2008, 3(7):147-149.
19. Xi B, Liang YJ, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009[J]. Int J Cardiol, 2012, 158(2):326-329.
20. Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-958.
21. 戚文威, 黄建凤, 李建新, 等. 中国人群饮酒与代谢综合征发病关系的前瞻性研究[J]. 中华健康管理学杂志, 2012, 6(2):75-80.

Previous Article
基于标准化的伤口数据云平台探讨
Next Article
Clinical Analysis of Cranial Venous Sinus Thrombosis

West China Medical Journal

Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content